Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome.

Zuber J, Frimat M, Caillard S, Kamar N, Gatault P, Petitprez F, Couzi L, Jourde-Chiche N, Chatelet V, Gaisne R, Bertrand D, Bamoulid J, Louis M, Sberro Soussan R, Navarro D, Westeel PF, Frimat L, Colosio C, Thierry A, Rivalan J, Albano L, Arzouk N, Cornec-Le Gall E, Claisse G, Elias M, El Karoui K, Chauvet S, Coindre JP, Rerolle JP, Tricot L, Sayegh J, Garrouste C, Charasse C, Delmas Y, Massy Z, Hourmant M, Servais A, Loirat C, Fakhouri F, Pouteil-Noble C, Peraldi MN, Legendre C, Rondeau E, Le Quintrec M, Frémeaux-Bacchi V.

J Am Soc Nephrol. 2019 Oct 1. pii: ASN.2019040331. doi: 10.1681/ASN.2019040331. [Epub ahead of print]

PMID:
31575699
2.

Adherence profiles in kidney transplant patients: Causes and consequences.

Villeneuve C, Rousseau A, Rerolle JP, Couzi L, Kamar N, Essig M, Etienne I, Westeel PF, Büchler M, Esposito L, Thierry A, Marquet P, Monchaud C.

Patient Educ Couns. 2019 Aug 7. pii: S0738-3991(19)30318-0. doi: 10.1016/j.pec.2019.08.002. [Epub ahead of print]

PMID:
31447197
3.

Kaposi Sarcoma in HIV-positive Solid-Organ Transplant Recipients: A French Multicentric National Study and Literature Review.

Charpentier C, Delyon J, Glotz D, Peraldi MN, Rerolle JP, Barrou B, Ducroux E, Coilly A, Legeai C, Barete S, Lebbé C.

Transplantation. 2019 Jan;103(1):e22-e28. doi: 10.1097/TP.0000000000002468. Review.

PMID:
30273235
4.

Pharmacokinetic Therapeutic Drug Monitoring of Advagraf in More Than 500 Adult Renal Transplant Patients, Using an Expert System Online.

Marquet P, Bedu A, Monchaud C, Saint-Marcoux F, Rérolle JP, Etienne I, Kamar N, Moulin B, Cassuto E, Essig M, Woillard JB.

Ther Drug Monit. 2018 Jun;40(3):285-291. doi: 10.1097/FTD.0000000000000503.

PMID:
29505493
5.

Kidney transplantation in patients with systemic sclerosis: a nationwide multicentre study.

Bertrand D, Dehay J, Ott J, Sberro R, Brunelle C, Kamar N, Colosio C, Chatelet V, Albano L, Girerd S, Audard V, Barbet C, Dantal J, Ducloux D, Durrbach A, Garrigue V, Hazzan M, Heng AE, Mariat C, Merville P, Rerolle JP, Moulin B, Guerrot D.

Transpl Int. 2017 Mar;30(3):256-265. doi: 10.1111/tri.12923.

6.

Multidrug resistance-associated protein 4 (MRP4) controls ganciclovir intracellular accumulation and contributes to ganciclovir-induced neutropenia in renal transplant patients.

Billat PA, Ossman T, Saint-Marcoux F, Essig M, Rerolle JP, Kamar N, Rostaing L, Kaminski H, Fabre G, Otyepka M, Woillard JB, Marquet P, Trouillas P, Picard N.

Pharmacol Res. 2016 Sep;111:501-508. doi: 10.1016/j.phrs.2016.07.012. Epub 2016 Jul 9. Review.

PMID:
27402191
7.

Genome-Wide Association Study of Acute Renal Graft Rejection.

Ghisdal L, Baron C, Lebranchu Y, Viklický O, Konarikova A, Naesens M, Kuypers D, Dinic M, Alamartine E, Touchard G, Antoine T, Essig M, Rerolle JP, Merville P, Taupin JL, Le Meur Y, Grall-Jezequel A, Glowacki F, Noël C, Legendre C, Anglicheau D, Broeders N, Coppieters W, Docampo E, Georges M, Ajarchouh Z, Massart A, Racapé J, Abramowicz D, Abramowicz M.

Am J Transplant. 2017 Jan;17(1):201-209. doi: 10.1111/ajt.13912. Epub 2016 Jul 22.

8.

Contribution of next generation sequencing to early detection of cytomegalovirus UL97 emerging mutants and viral subpopulations analysis in kidney transplant recipients.

Garrigue I, Moulinas R, Recordon-Pinson P, Delacour ML, Essig M, Kaminski H, Rerolle JP, Merville P, Fleury H, Alain S.

J Clin Virol. 2016 Jul;80:74-81. doi: 10.1016/j.jcv.2016.04.017. Epub 2016 Apr 27.

PMID:
27214758
9.

A candidate gene approach of the calcineurin pathway to identify variants associated with clinical outcomes in renal transplantation.

Pouché L, Koitka M, Stojanova J, Woillard JB, Monchaud C, Villeneuve C, Essig M, Abraham J, Le Meur Y, Rerolle JP, Kamar N, Rostaing L, Merville P, Gandia P, Bouchet S, Petersen BS, Marquet P, Picard N.

Pharmacogenomics. 2016 Mar;17(4):375-91. doi: 10.2217/pgs.15.181. Epub 2016 Feb 19.

PMID:
26894651
10.

A Lack of Significant Effect of POR*28 Allelic Variant on Tacrolimus Exposure in Kidney Transplant Recipients.

Jannot AS, Vuillemin X, Etienne I, Buchler M, Hurault de Ligny B, Choukroun G, Colosio C, Thierry A, Vigneau C, Moulin B, Rerolle JP, Heng AE, Subra JF, Legendre C, Beaune P, Loriot MA, Thervet E, Pallet N.

Ther Drug Monit. 2016 Apr;38(2):223-9. doi: 10.1097/FTD.0000000000000267.

PMID:
26829596
11.

Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.

Thierry A, Le Meur Y, Ecotière L, Abou-Ayache R, Etienne I, Laurent C, Vuiblet V, Colosio C, Bouvier N, Aldigier JC, Rerolle JP, Javaugue V, Gand E, Bridoux F, Essig M, Hurault de Ligny B, Touchard G.

Transpl Int. 2016 Jan;29(1):23-33. doi: 10.1111/tri.12627. Erratum in: Transpl Int. 2016 Jul;29(7):833. Lemeur, Yann [corrected to Le Meur, Yannick].

12.

One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled Trial.

Sautenet B, Blancho G, Büchler M, Morelon E, Toupance O, Barrou B, Ducloux D, Chatelet V, Moulin B, Freguin C, Hazzan M, Lang P, Legendre C, Merville P, Mourad G, Mousson C, Pouteil-Noble C, Purgus R, Rerolle JP, Sayegh J, Westeel PF, Zaoui P, Boivin H, Le Gouge A, Lebranchu Y.

Transplantation. 2016 Feb;100(2):391-9. doi: 10.1097/TP.0000000000000958.

PMID:
26555944
13.

Eight-year results of the Spiesser study, a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation.

Gatault P, Bertrand D, Büchler M, Colosio C, Hurault de Ligny B, Weestel PF, Rerolle JP, Thierry A, Sayegh J, Moulin B, Snanoudj R, Rivalan J, Heng AE, Sautenet B, Lebranchu Y.

Transpl Int. 2016 Jan;29(1):41-50. doi: 10.1111/tri.12656.

14.

The clinical status and survival in elderly dialysis: example of the oldest region of France.

Glaudet F, Hottelart C, Allard J, Allot V, Bocquentin F, Boudet R, Champtiaux B, Charmes JP, Ciobotaru M, Dickson Z, Essig M, Honoré P, Lacour C, Lagarde C, Manescu M, Peyronnet P, Poux JM, Rerolle JP, Rincé M, Couchoud C, Aldigier JC; REIN Limousin.

BMC Nephrol. 2013 Jun 25;14:131. doi: 10.1186/1471-2369-14-131.

15.

Impact of longitudinal exposure to mycophenolic acid on acute rejection in renal-transplant recipients using a joint modeling approach.

Daher Abdi Z, Essig M, Rizopoulos D, Le Meur Y, Prémaud A, Woillard JB, Rérolle JP, Marquet P, Rousseau A.

Pharmacol Res. 2013 Jun;72:52-60. doi: 10.1016/j.phrs.2013.03.009. Epub 2013 Apr 1.

16.

Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.

Caillard S, Porcher R, Provot F, Dantal J, Choquet S, Durrbach A, Morelon E, Moal V, Janbon B, Alamartine E, Pouteil Noble C, Morel D, Kamar N, Buchler M, Mamzer MF, Peraldi MN, Hiesse C, Renoult E, Toupance O, Rerolle JP, Delmas S, Lang P, Lebranchu Y, Heng AE, Rebibou JM, Mousson C, Glotz D, Rivalan J, Thierry A, Etienne I, Moal MC, Albano L, Subra JF, Ouali N, Westeel PF, Delahousse M, Genin R, Hurault de Ligny B, Moulin B.

J Clin Oncol. 2013 Apr 1;31(10):1302-9. doi: 10.1200/JCO.2012.43.2344. Epub 2013 Feb 19.

PMID:
23423742
17.

Bordetella holmesii bacteremia in a renal transplant recipient: emergence of a new pathogen.

Chambaraud T, Dickson Z, Ensergueix G, Barraud O, Essig M, Lacour C, Allard J, Bocquentin F, Aldigier JC, Rerolle JP.

Transpl Infect Dis. 2012 Dec;14(6):E134-6. doi: 10.1111/tid.12009. Epub 2012 Sep 24.

PMID:
22998023
18.

De novo kidney graft tumors: results from a multicentric retrospective national study.

Tillou X, Doerfler A, Collon S, Kleinclauss F, Patard JJ, Badet L, Barrou B, Audet M, Bensadoun H, Berthoux E, Bigot P, Boutin JM, Bouzguenda Y, Chambade D, Codas R, Dantal J, Deturmeny J, Devonec M, Dugardin F, Ferrière JM, Erauso A, Feuillu B, Gigante M, Guy L, Karam G, Lebret T, Neuzillet Y, Legendre C, Perez T, Rerolle JP, Salomon L, Sallusto F, Sénéchal C, Terrier N, Thuret R, Verhoest G, Petit J; “Comité de Transplantation de l’Association Française d’Urologie (CTAFU)”.

Am J Transplant. 2012 Dec;12(12):3308-15. doi: 10.1111/j.1600-6143.2012.04248.x. Epub 2012 Sep 7.

19.

Five-year results of a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation: the SPIESSER study.

Lebranchu Y, Snanoudj R, Toupance O, Weestel PF, Hurault de Ligny B, Buchler M, Rerolle JP, Thierry A, Moulin B, Subra JF, Deteix P, Le Pogamp P, Finzi L, Etienne I.

Am J Transplant. 2012 Jul;12(7):1801-10. doi: 10.1111/j.1600-6143.2012.04036.x. Epub 2012 Apr 5.

20.

Conversion from everolimus with low-exposure cyclosporine to everolimus with mycophenolate sodium maintenance therapy in kidney transplant recipients: a randomized, open-label multicenter study.

Albano L, Alamartine E, Toupance O, Moulin B, Merville P, Rerolle JP, Tetaz R, Moal MC, Kamar N, Legendre C, Quéré S, Di Giambattista F, Terpereau A, Dantal J.

Ann Transplant. 2012 Jan-Mar;17(1):58-67.

PMID:
22466910
21.

Early steroid withdrawal and optimization of mycophenolic acid exposure in kidney transplant recipients receiving mycophenolate mofetil.

Le Meur Y, Thierry A, Glowacki F, Rerolle JP, Garrigue V, Ouali N, Heng AE, Delahousse M, Albano L, Lang P, Couzi L, Jaureguy M, Lebranchu Y, Mousson C, Glotz D, Kessler M, Vrtovsnik F, Rouanet S, Tagieva N, Kamar N.

Transplantation. 2011 Dec 15;92(11):1244-51. doi: 10.1097/TP.0b013e318234e134.

PMID:
22067312
22.

Efficacy and safety of early cyclosporine conversion to sirolimus with continued MMF-four-year results of the Postconcept study.

Lebranchu Y, Thierry A, Thervet E, Büchler M, Etienne I, Westeel PF, Hurault de Ligny B, Moulin B, Rérolle JP, Frouget T, Girardot-Seguin S, Toupance O.

Am J Transplant. 2011 Aug;11(8):1665-75. doi: 10.1111/j.1600-6143.2011.03637.x.

23.

Acute renal failure following allogeneic hematopoietic cell transplantation: incidence, outcome and risk factors.

Helal I, Byzun A, Rerolle JP, Morelon E, Kreis H, Bruneel-Mamzer MF.

Saudi J Kidney Dis Transpl. 2011 May;22(3):437-43.

24.

Drug-resistant cytomegalovirus in transplant recipients: a French cohort study.

Hantz S, Garnier-Geoffroy F, Mazeron MC, Garrigue I, Merville P, Mengelle C, Rostaing L, Saint Marcoux F, Essig M, Rerolle JP, Cotin S, Germi R, Pillet S, Lebranchu Y, Turlure P, Alain S; French CMV Resistance Survey Study Group.

J Antimicrob Chemother. 2010 Dec;65(12):2628-40. doi: 10.1093/jac/dkq368. Epub 2010 Oct 20.

PMID:
20961907
25.

Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8 2 variant allele.

Woillard JB, Rerolle JP, Picard N, Rousseau A, Drouet M, Munteanu E, Essig M, Marquet P, Le Meur Y.

Br J Clin Pharmacol. 2010 Jun;69(6):675-83. doi: 10.1111/j.1365-2125.2010.03625.x.

26.

Donor P-gp polymorphisms strongly influence renal function and graft loss in a cohort of renal transplant recipients on cyclosporine therapy in a long-term follow-up.

Woillard JB, Rerolle JP, Picard N, Rousseau A, Guillaudeau A, Munteanu E, Essig M, Drouet M, Le Meur Y, Marquet P.

Clin Pharmacol Ther. 2010 Jul;88(1):95-100. doi: 10.1038/clpt.2010.62. Epub 2010 May 26.

27.

Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial.

Dantal J, Berthoux F, Moal MC, Rostaing L, Legendre C, Genin R, Toupance O, Moulin B, Merville P, Rerolle JP, Bayle F, Westeel PF, Glotz D, Kossari N, Lefrançois N, Charpentier B, Quéré S, Di Giambattista F, Cassuto E; RAD A2420 Study Group.

Transpl Int. 2010 Nov;23(11):1084-93. doi: 10.1111/j.1432-2277.2010.01094.x. Epub 2010 Aug 19. Erratum in: Transpl Int. 2012 Jan;25(1):138.

28.

Severe sirolimus-induced acute hepatitis in a renal transplant recipient.

Jacques J, Dickson Z, Carrier P, Essig M, Guillaudeau A, Lacour C, Bocquentin F, Aldigier JC, Rerolle JP.

Transpl Int. 2010 Sep;23(9):967-70. doi: 10.1111/j.1432-2277.2010.01100.x. Epub 2010 May 20.

29.

Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients.

Benkali K, Prémaud A, Picard N, Rérolle JP, Toupance O, Hoizey G, Turcant A, Villemain F, Le Meur Y, Marquet P, Rousseau A.

Clin Pharmacokinet. 2009;48(12):805-16. doi: 10.2165/11318080-000000000-00000.

PMID:
19902988
30.

TCF7L2 polymorphism associates with new-onset diabetes after transplantation.

Ghisdal L, Baron C, Le Meur Y, Lionet A, Halimi JM, Rerolle JP, Glowacki F, Lebranchu Y, Drouet M, Noël C, El Housni H, Cochaux P, Wissing KM, Abramowicz D, Abramowicz M.

J Am Soc Nephrol. 2009 Nov;20(11):2459-67. doi: 10.1681/ASN.2008121314. Epub 2009 Aug 27.

31.

A renal transplant recipient with intraglomerular Candida albicans.

Dickson Z, Bocquentin F, Essig M, Paraf F, Aldigier JC, Rérolle JP.

NDT Plus. 2009 Aug;2(4):329-30. doi: 10.1093/ndtplus/sfp051. Epub 2009 Apr 23. No abstract available.

32.

Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.

Albano L, Berthoux F, Moal MC, Rostaing L, Legendre C, Genin R, Toupance O, Moulin B, Merville P, Rerolle JP, Bayle F, Westeel PF, Glotz D, Kossari N, Lefrançois N, Charpentier B, Blanc AS, Di Giambattista F, Dantal J; RAD A2420 Study Group.

Transplantation. 2009 Jul 15;88(1):69-76. doi: 10.1097/TP.0b013e3181aa7d87.

PMID:
19584683
33.

A new strategy for faster urinary biomarkers identification by Nano-LC-MALDI-TOF/TOF mass spectrometry.

Benkali K, Marquet P, Rérolle J, Le Meur Y, Gastinel L.

BMC Genomics. 2008 Nov 14;9:541. doi: 10.1186/1471-2164-9-541.

34.

An unusual pulmonary complication of cytomegalovirus infection in a renal transplant recipient.

Jacques J, Dallocchio A, Dickson Z, Bocquentin F, Jebali H, Aldigier JC, Essig M, Rerolle JP.

NDT Plus. 2008 Aug;1(4):236-8. doi: 10.1093/ndtplus/sfn055. Epub 2008 May 21. No abstract available.

35.

PAI-1 donor polymorphism influences long-term kidney graft survival.

Rérolle JP, Munteanu E, Drouet M, Szelag JC, Champtiaux B, Yagoubi F, Preux PM, Aldigier JC, Le Meur Y.

Nephrol Dial Transplant. 2008 Oct;23(10):3325-32. doi: 10.1093/ndt/gfn241. Epub 2008 May 7.

PMID:
18463321
36.

Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation.

Le Meur Y, Büchler M, Thierry A, Caillard S, Villemain F, Lavaud S, Etienne I, Westeel PF, Hurault de Ligny B, Rostaing L, Thervet E, Szelag JC, Rérolle JP, Rousseau A, Touchard G, Marquet P.

Am J Transplant. 2007 Nov;7(11):2496-503. Epub 2007 Oct 1.

37.

Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patients.

Djebli N, Picard N, Rérolle JP, Le Meur Y, Marquet P.

Pharmacogenet Genomics. 2007 May;17(5):321-30.

PMID:
17429314
38.

Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients.

Djebli N, Rousseau A, Hoizey G, Rerolle JP, Toupance O, Le Meur Y, Marquet P.

Clin Pharmacokinet. 2006;45(11):1135-48.

PMID:
17048977
39.

Unexpected rate of severe leucopenia with the association of mycophenolate mofetil and valganciclovir in kidney transplant recipients.

Rerolle JP, Szelag JC, Le Meur Y.

Nephrol Dial Transplant. 2007 Feb;22(2):671-2. Epub 2006 Sep 15. No abstract available.

PMID:
16980323
40.

[Renal transplantation in the elderly: a survey].

Rerolle JP, Szelag JC, Diaconita M, Saada F, Aldigier JC, Le Meur Y.

Nephrol Ther. 2006 Feb;2(1):8-14. Epub 2006 Feb 17. French.

PMID:
16895710
41.

CYP3A5*3 influences sirolimus oral clearance in de novo and stable renal transplant recipients.

Le Meur Y, Djebli N, Szelag JC, Hoizey G, Toupance O, Rérolle JP, Marquet P.

Clin Pharmacol Ther. 2006 Jul;80(1):51-60.

PMID:
16815317
42.

Intracranial granuloma and skull osteolysis: complication of a primary cutaneous cryptococcosis in a kidney transplant recipient.

Rerolle JP, Szelag JC, Diaconita M, Paraf F, Aldigier JC, Le Meur Y.

Am J Kidney Dis. 2005 Dec;46(6):e113-7.

PMID:
16310562
43.

Long-term successful outcome of sequential cardiac and allogeneic bone marrow transplantations in severe AL amyloidosis.

Thaunat O, Alyanakian MA, Varnous S, Bors V, Damaj G, Rerolle JP, Jondeau K, Varet B, Gandjbakhch I, Buzyn A.

Bone Marrow Transplant. 2005 Feb;35(4):419-20. No abstract available.

PMID:
15640825
44.

Parvovirus B19-related anaemia after renal transplantation.

Rerolle JP, Morelon E, Helal I, Peraldi MN, Mamzer-Bruneel MF, Kreis H.

Scand J Infect Dis. 2004;36(6-7):513-6.

PMID:
15307588
45.

Thrombotic microangiopathy and hypothermia in an HIV-positive patient: importance of cytomegalovirus infection.

Rerolle JP, Canaud G, Fakhouri F, Aaron L, Morelon E, Peraldi MN, Kreis H, Bruneel MF.

Scand J Infect Dis. 2004;36(3):234-7.

PMID:
15119375
46.

[Parvovirus B19 infection after renal transplantation].

Rerolle JP, Helal I, Morelon E.

Nephrologie. 2003;24(6):309-15. Review. French.

PMID:
14584298
47.

[Telephone activity in outpatient pediatric practice].

Assathiany R, Rerolle JM, Messica C, Chevallier B, Odievre M, Arepege.

Arch Pediatr. 2003 Aug;10(8):689-93. French.

PMID:
12922000
48.

Veno-occlusive disease of the liver in renal transplant patients.

Vallet-Pichard A, Rerolle JP, Fontaine H, Larousserie F, Peraldi MN, Kreis H, Pol S.

Nephrol Dial Transplant. 2003 Aug;18(8):1663-6. No abstract available.

PMID:
12897112
49.

An unusual recurrence of crescentic nephritis after renal transplantation for IgA nephropathy.

Benabdallah L, Rerolle JP, Peraldi MN, Noël LH, Bruneel MF, Carron PL, Morelon E, Kreis H.

Am J Kidney Dis. 2002 Dec;40(6):E20.

PMID:
12460065
50.

Long-term renal allograft outcome after simultaneous kidney and pancreas transplantation.

Rerolle JP, Thervet E, Anglicheau D, Desgrandchamps F, Nochy D, Janin A, Fornairon S, Passa P, Bedrossian J, Legendre C.

Nephrol Dial Transplant. 2002 May;17(5):905-9.

PMID:
11981082

Supplemental Content

Loading ...
Support Center